Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Overland Park, Kansas


Purpose:

Study evaluates the drug-drug interaction between Ticagrelor and Venlafaxine when taken together in healthy volunteers


Criteria:

Inclusion Criteria: - a weight of at least 50 kg and a body mass index between 18 to 30 kg/m2 Exclusion Criteria: - History of clinically significant disease or disorder as judged by the investigator - Any clinically significant illness, medical/surgical procedure or trauma within 4 weeks of the first administration of drug. - History of haemophilia, von Willebrand´s disease, lupus anticoagulant or other diseases/syndromes that may alter or increase bleeding. - History of previous or ongoing psychiatric disease


NCT ID:

NCT01350921


Primary Contact:

Study Director
Jay Horrow, PhD
AstraZeneca Wilmington


Backup Contact:

N/A


Location Contact:

Overland Park, Kansas
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.